Cargando…
Paliperidone ER: a review of the clinical trial data
Paliperidone extended-release tablet (paliperidone ER; INVEGA(™)) is an oral antipsychotic for the treatment of schizophrenia. The recommended dose range is 3–12 mg per day. Paliperidone ER utilizes the OROS(®) delivery system, which allows for once-daily dosing. Its pharmacokinetic profile results...
Autores principales: | Janicak, Philip G, Winans, Elizabeth A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656329/ https://www.ncbi.nlm.nih.gov/pubmed/19300622 |
Ejemplares similares
-
Once-monthly paliperidone injection for the treatment of schizophrenia
por: Bishara, Delia
Publicado: (2010) -
Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia
por: Turkoz, Ibrahim, et al.
Publicado: (2008) -
A sneak peek into the Early Career Members’ session at the ERS International Congress and the experience of organising an ERS Research Seminar
por: Collins, Jennifer J.P., et al.
Publicado: (2020) -
Zooming in on the ERS fellowships and the International Congress
por: Nenna, Raffaella, et al.
Publicado: (2018) -
ERS ECM Awardee 2021, a preview of LSC 2022 and a brief overview of the Respiratory Channel
por: Costa, João C., et al.
Publicado: (2021)